Cell Rep. 2026 Nov 14;45(11):118282. doi: 10.1016/j.celrep.2026.118282. Online ahead of print.
ABSTRACT
Clear cell renal cell carcinoma (ccRCC) is characterized by aberrant lipid accumulation and intrinsic ferroptosis sensitivity, yet how ccRCC escapes this vulnerability remains poorly understood. Here, we report that fumarate hydratase (FH) deficiency drives fumarate accumulation, which induces extensive remodeling of the ubiquitinated proteome and confers increased resistance to ferroptosis in ccRCC. Mechanistically, fumarate-mediated C706 succination of ubiquitin-like modifier-activating enzyme 1 (UBA1) significantly impairs its interaction with ubiquitin-conjugating enzyme E2 G2 (UBE2G2), concomitant with a global reduction of ubiquitination. Specifically, diminished ubiquitination increases the protein levels of activating transcription factor 4 (ATF4) and elevates solute carrier family 7 member 11 (SLC7A11) expression, thereby inhibiting ferroptosis. Importantly, a designed cell-penetrating peptide attenuates fumarate-induced UBA1 succination, suppresses ATF4-SLC7A11 axis, and enhances ferroptosis sensitivity of ccRCC. Collectively, these findings reveal that FH deficiency drives ubiquitinome dysregulation and suppresses ferroptosis, thereby linking ubiquitinated proteome reprogramming to tumor progression and suggesting potential therapeutic targets and strategies for treating ccRCC.
PMID:43033438 | DOI:10.1016/j.celrep.2026.118282

